4 research outputs found
Valutazione a distanza dell\ue2\u20ac\u2122efficacia dell\ue2\u20ac\u2122applicazione di un protocollo estrattivo per la prevenzione dell\ue2\u20ac\u2122osteonecrosi dei mascellari in pazienti in trattamento con aminobisfosfonati.
Osteomalacia: The Missing Link in the Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaws?
none13noAbstractBackground. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a well-documented adverse event from treatment with nitrogen-containing bisphosphonates (NBPs). During a preliminary histomorphometric study aimed at assessing the rate of bone remodeling in the jaws of patient with surgically resected BRONJ, we found a defect of bone mineralization (unpublished data). We hypothesized that osteomalacia could be a risk factor for BRONJ in patients taking NBPs. Therefore, we looked for static and dynamic histomorphometric evidence of osteomalacia in biopsies from subjects with and without BRONJ.Methods. This case-control study used histomorphometric analysis of bone specimens of patients using NBPs (22 patients with BRONJ and 21 patients without BRONJ) who required oral surgical interventions for the treatment/prevention of osteonecrosis. Patients were given tetracycline hydrochloride according to a standardized protocol before taking bone biopsies from their jaws. Biopsies with evidence of osteomyelitis or necrosis at histology were excluded from the study. Osteomalacia was defined as a mineralization lag time >100 days, a corrected mean osteoid thickness >12.5 mm, and an osteoid volume >10%.Results. In all, 77% of patients with BRONJ were osteomalacic compared with 5% of patients without BRONJ, according to histomorphometry. Because osteomalacia was found almost exclusively in NBP users with BRONJ, this is likely to be a generalized process in which the use of NBPs further deteriorates mechanisms of bone repair.Conclusions. Osteomalacia represents a new and previously unreported risk factor for disease development. This finding may contribute to a better understanding of the pathogenesis of this disease and help with the development of strategies to increase the safety of NBP administration.mixedA. Bedogni;G. Saia;G. Bettini;A. Tronchet;A. Totola;G. Bedogni;P. Tregnago;M. T. Valenti;F. Bertoldo;G. Ferronato;P. F. Nocini;S. Blandamura;L. Dalle CarbonareBedogni, Alberto; Saia, Giorgia; Bettini, G.; Tronchet, A.; Totola, A.; Bedogni, G.; Tregnago, P.; Valenti, M. T.; Bertoldo, F.; Ferronato, Giuseppe; Nocini, P. F.; Blandamura, Stella; Dalle Carbonare, L